Abiraterone
Formulations: - Oral > Solid: 250 mg; 500 mg Indications: - Malignant neoplasms of prostate Source: EML workbook import
MOQ: 1
Kes0.00
Product image unavailable
Methylprednisolone
Vendor: Marketplace supplier
Formulations:
- Parenteral > General injections > IV: 40 mg in vial (as sodium succinate); 125 mg in vial (as sodium succinate)
Parenteral > General injections > IV: 40 mg in vial (as sodium succinate) powder for injection; 125 mg in vial (as sodium succinate) powder for injection
Indications:
- Burkitt lymphoma including Burkitt leukaemia
- Lymphoid leukaemia, not elsewhere classified
Source: EML workbook import
Product metadata will be available once the catalog entry is complete.
Kes0.00
Availability
Supplier and price will be confirmed during RFQ.
Formulations:
- Parenteral > General injections > IV: 40 mg in vial (as sodium succinate); 125 mg in vial (as sodium succinate)
Parenteral > General injections > IV: 40 mg in vial (as sodium succinate) powder for injection; 125 mg in vial (as sodium succinate) powder for injection
Indications:
- Burkitt lymphoma including Burkitt leukaemia
- Lymphoid leukaemia, not elsewhere classified
Source: EML workbook import
Similar Products
Anastrozole
Formulations: - Oral > Solid: 1 mg tablet Indications: - Other specified malignant neoplasms of breast - Malignant neoplasms of breast Source: EML workbook import
MOQ: 1
Kes0.00
Bicalutamide
Formulations: - Oral > Solid: 50 mg Indications: - Malignant neoplasms of prostate Source: EML workbook import
MOQ: 1
Kes0.00
Enzalutamide
Formulations: - Oral > Solid: 40 mg Indications: - Malignant neoplasms of prostate Source: EML workbook import
MOQ: 1
Kes0.00
Goserelin
Indications: - Malignant neoplasms of breast - Malignant neoplasms of prostate Source: EML workbook import
MOQ: 1
Kes0.00
Sign Up to Our Newsletter→
Ready to amplify your rewards? Drop your email and we'll be in touch soon.